➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKesson
Moodys
Harvard Business School
AstraZeneca

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

SYNALAR Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Synalar, and when can generic versions of Synalar launch?

Synalar is a drug marketed by Medimetriks Pharms and is included in four NDAs.

The generic ingredient in SYNALAR is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

Drug patent expirations by year for SYNALAR
Drug Prices for SYNALAR

See drug prices for SYNALAR

Recent Clinical Trials for SYNALAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Noah Rosenberg, MDPhase 4
LEO PharmaPhase 1

See all SYNALAR clinical trials

Pharmacology for SYNALAR

US Patents and Regulatory Information for SYNALAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medimetriks Pharms SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-004 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide OINTMENT;TOPICAL 013960-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-002 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
Medimetriks Pharms SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-005 Approved Prior to Jan 1, 1982 AT RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Colorcon
Harvard Business School
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.